Kavita Patel, PIF President: “We see steps forward with HTA, but several improvements are still necessary.”
The new HTA framework takes some steps towards value-based assessment; however, further improvements are still needed to ensure timely and sustainable patient access to new therapies. These include establishing clear methodologies and procedures, as well as consulting with pharmaceutical companies throughout the assessment process. The critical role of Health Technology Assessment (HTA), the contribution…